The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B

Molecular Biology of the Cell

Volumn 25, Issue 18, 2014, Pages 2761-2773

  Britigan, Eric M C ^a,b   Wan, Jun ^a,b   Zasadil, Lauren M ^a,b   Ryan, Sean D ^a   Weaver, Beth A ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF TUMOR SUPPRESSOR PROTEIN; AURORA B KINASE; BUB1 RELATED PROTEIN; PROTEIN MAD2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; AURKB PROTEIN, MOUSE; BUB1B PROTEIN, MOUSE; CDKN2A PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MAD2L1 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

ANAPHASE; ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRIOLE; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME 11; CHROMOSOME NUMBER; CHROMOSOME SEGREGATION; CONTROLLED STUDY; CYTOKINESIS; DNA CONTENT; EMBRYO; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERPHASE; M PHASE CELL CYCLE CHECKPOINT; METAPHASE; MICROTUBULE; MITOSIS; MITOSIS INDEX; MITOSIS INHIBITION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPINDLE CELL; SPLEEN CELL; TELOPHASE; TETRAPLOIDY; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; ENZYME STABILITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HALF LIFE TIME; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANEUPLOIDY; ANIMALS; AURORA KINASE B; CELL CYCLE PROTEINS; CELLS, CULTURED; CHROMOSOMAL INSTABILITY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ENZYME STABILITY; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HALF-LIFE; MAD2 PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOSIS; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES;

EID: 84907202351     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E14-05-0966     Document Type: Article

References (93)

1. Araki K, Nozaki K, Ueba T, Tatsuka M, Hashimoto N (2004). High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas. J Neurooncol 67, 53-64.
2. Baker DJ, Dawlaty MM, Wijshake T, Jeganathan KB, Malureanu L, van Ree JH, Crespo-Diaz R, Reyes S, Seaburg L, Shapiro V, et al. (2013). Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol 15, 96-102.
3. Baker DJ, Jeganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A, Kumar R, Jenkins RB, de Groen PC, Roche P, et al. (2004). BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 36, 744-749.
4. Baker DJ, Jeganathan KB, Malureanu L, Perez-Terzic C, Terzic A, van Deursen JM (2006). Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J Cell Biol 172, 529-540.
5. Biggins S, Murray AW (2001). The budding yeast protein kinase Ipl1/Aurora allows the absence of tension to activate the spindle checkpoint. Genes Dev 15, 3118-3129.
6. Biggins S, Severin FF, Bhalla N, Sassoon I, Hyman AA, Murray AW (1999). The conserved protein kinase Ipl1 regulates microtubule binding to kinetochores in budding yeast. Genes Dev 13, 532-544.
7. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, et al. (1998). A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 17, 3052-3065.
8. Bothner B, Lewis WS, DiGiammarino EL, Weber JD, Bothner SJ, Kriwacki RW (2001). Defining the molecular basis of Arf and Hdm2 interactions. J Mol Biol 314, 263-277.
9. Brown KD, Wood KW, Cleveland DW (1996). The kinesin-like protein CENP-E is kinetochore-associated throughout poleward chromosome segregation during anaphase-A. J Cell Sci 109, 961-969.
10. Chen RH, Shevchenko A, Mann M, Murray AW (1998). Spindle checkpoint protein Xmad1 recruits Xmad2 to unattached kinetochores. J Cell Biol 143, 283-295.
11. Chen YJ, Chen CM, Twu NF, Yen MS, Lai CR, Wu HH, Wang PH, Yuan CC (2009). Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients. Virchows Arch 455, 431-440.
12. Chieffi P, Cozzolino L, Kisslinger A, Libertini S, Staibano S, Mansueto G, De Rosa G, Villacci A, Vitale M, Linardopoulos S, et al. (2006). Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 66, 326-333.
13. Cimini D, Howell B, Maddox P, Khodjakov A, Degrassi F, Salmon ED (2001). Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J Cell Biol 153, 517-527.
14. Cimini D, Wan X, Hirel CB, Salmon ED (2006). Aurora kinase promotes turnover of kinetochore microtubules to reduce chromosome segregation errors. Curr Biol 16, 1711-1718.
15. Cooke CA, Heck MM, Earnshaw WC (1987). The inner centromere protein (INCENP) antigens: movement from inner centromere to midbody during mitosis. J Cell Biol 105, 2053-2067.
16. Courapied S, Cherier J, Vigneron A, Troadec MB, Giraud S, Valo I, Prigent C, Gamelin E, Coqueret O, Barré B (2010). Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription factor. Mol Cancer 9, 205.
17. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ (1995). A p53-dependent mouse spindle checkpoint. Science 267, 1353-1356.
18. Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S, Mahmood R, Yang YM, Xu M, Rao CV (2004). Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res 64, 440-445.
19. Datta A, Sen J, Hagen J, Korgaonkar CK, Caffrey M, Quelle DE, Hughes DE, Ackerson TJ, Costa RH, Raychaudhuri P (2005). ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF. Mol Cell Biol 25, 8024-8036.
20. den Hollander J, Rimpi S, Doherty JR, Rudelius M, Buck A, Hoellein A, Kremer M, Graf N, Scheerer M, Hall MA, et al. (2010). Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood 116, 1498-1505.
21. Di Leonardo A, Khan SH, Linke SP, Greco V, Seidita G, Wahl GM (1997). DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res 57, 1013-1019.
22. Ditchfield C, Johnson VL, Tighe A, Ellston R, Haworth C, Johnson T, Mortlock A, Keen N, Taylor SS (2003). Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 161, 267-280.
23. di Tommaso A, Hagen J, Tompkins V, Muniz V, Dudakovic A, Kitzis A, Ladeveze V, Quelle DE (2009). Residues in the alternative reading frame tumor suppressor that influence its stability and p53-independent activities. Exp Cell Res 315, 1326-1335.
24. Dobles M, Liberal V, Scott ML, Benezra R, Sorger PK (2000). Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 101, 635-645.
25. Ehara H, Yokoi S, Tamaki M, Nishino Y, Takahashi Y, Deguchi T, Kimura M, Yoshioka T, Okano Y (2003). Expression of mitotic Aurora/Ipl1p-related kinases in renal cell carcinomas: an immunohistochemical study. Urol Res 31, 382-386.
26. Eymin B, Claverie P, Salon C, Leduc C, Col E, Brambilla E, Khochbin S, Gazzeri S (2006). p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress. Mol Cell Biol 26, 4339-4350.
27. Eymin B, Leduc C, Coll JL, Brambilla E, Gazzeri S (2003). p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene 22, 1822-1835.
28. Fang G, Yu H, Kirschner MW (1998). The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev 12, 1871-1883.
29. Ganem NJ, Godinho SA, Pellman D (2009). A mechanism linking extra centrosomes to chromosomal instability. Nature 460, 278-282.
30. Gupta RS (1985). Species-specific differences in toxicity of antimitotic agents toward cultured mammalian cells. J Natl Cancer Inst 74, 159-164.
31. Haller K, Kibler KV, Kasai T, Chi YH, Peloponese JM, Yedavalli VS, Jeang KT (2006). The N-terminus of rodent and human MAD1 confers species-specific stringency to spindle assembly checkpoint. Oncogene 25, 2137-2147.
32. Han J-S, Holland AJ, Fachinetti D, Kulukian A, Cetin B, Cleveland DW (2013). Catalytic Assembly of the mitotic checkpoint inhibitor BubR1-Cdc20 by Mad2-induced functional switch in Cdc20. Mol Cell 51, 92-104.
33. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A, Donehower LA (1993). In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8, 2457-2467.
34. Hauf S, Cole RW, LaTerra S, Zimmer C, Schnapp G, Walter R, Heckel A, van Meel J, Rieder CL, Peters JM (2003). The small molecule hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J Cell Biol 161, 281-294.
35. He X, Patterson TE, Sazer S (1997). The Schizosaccharomyces pombe spindle checkpoint protein mad2p blocks anaphase and genetically interacts with the anaphase-promoting complex. Proc Natl Acad Sci USA 94, 7965-7970.
36. Holland AJ, Cleveland DW (2009). Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 10, 478-487.
37. Honda R, Körner R, Nigg EA (2003). Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol Biol Cell 14, 3325-3341.
38. Honda R, Tanaka H, Yasuda H (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420, 25-27.
39. Honda R, Yasuda H (1999). Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 18, 22-27.
40. Howell BJ, Hoffman DB, Fang G, Murray AW, Salmon ED (2000). Visualization of Mad2 dynamics at kinetochores, along spindle fibers, and at spindle poles in living cells. J Cell Biol 150, 1233-1250.
41. Hoyt MA, Totis L, Roberts BT (1991). S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66, 507-517.
42. Kalinichenko VV, Major ML, Wang X, Petrovic V, Kuechle J, Yoder HM, Dennewitz MB, Shin B, Datta A, Raychaudhuri P, et al. (2004). Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 18, 830-850.
43. Kallio MJ, McCleland ML, Stukenberg PT, Gorbsky GJ (2002). Inhibition of Aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis. Curr Biol 12, 900-905.
44. Kienitz A, Vogel C, Morales I, Muller R, Bastians H (2005). Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards Taxol. Oncogene 24, 4301-4310.
45. Kim SH, Lin DP, Matsumoto S, Kitazono A, Matsumoto T (1998). Fission yeast Slp1: an effector of the Mad2-dependent spindle checkpoint. Science 279, 1045-1047.
46. King EM, Rachidi N, Morrice N, Hardwick KG, Stark MJ (2007). Ipl1p-dependent phosphorylation of Mad3p is required for the spindle checkpoint response to lack of tension at kinetochores. Genes Dev 21, 1163-1168.
47. Komlodi-Pasztor E, Sackett DL, Fojo AT (2012). Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale. Clin Cancer Res 18, 51-63.
48. Kops GJ, Kim Y, Weaver BA, Mao Y, McLeod I, Yates JR 3rd, Tagaya M, Cleveland DW (2005). ZW10 links mitotic checkpoint signaling to the structural kinetochore. J Cell Biol 169, 49-60.
49. Korgaonkar C, Zhao L, Modestou M, Quelle DE (2002). ARF function does not require p53 stabilization or Mdm2 relocalization. Mol Cell Biol 22, 196-206.
50. Kulukian A, Han JS, Cleveland DW (2009). Unattached kinetochores catalyze production of an anaphase inhibitor that requires a Mad2 template to prime Cdc20 for BubR1 binding. Dev Cell 16, 105-117.
51. Kung AL, Sherwood SW, Schimke RT (1990). Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc Natl Acad Sci USA 87, 9553-9557.
52. Lan W, Zhang X, Kline-Smith SL, Rosasco SE, Barrett-Wilt GA, Shabanowitz J, Hunt DF, Walczak CE, Stukenberg PT (2004). Aurora B phosphorylates centromeric MCAK and regulates its localization and microtubule depolymerization activity. Curr Biol 14, 273-286.
53. Lanni JS, Jacks T (1998). Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 18, 1055-1064.
54. Laoukili J, Kooistra MR, Brás A, Kauw J, Kerkhoven RM, Morrison A, Clevers H, Medema RH (2005). FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7, 126-136.
55. Li R, Murray AW (1991). Feedback control of mitosis in budding yeast. Cell 66, 519-531.
56. Lin ZZ, Jeng YM, Hu FC, Pan HW, Tsao HW, Lai PL, Lee PH, Cheng AL, Hsu HC (2010). Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B overexpression in HCC. BMC Cancer 10, 461.
57. Meraldi P, Draviam VM, Sorger PK (2004). Timing and checkpoints in the regulation of mitotic progression. Dev Cell 7, 45-60.
58. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R (2001). MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409, 355-359.
59. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245.
60. Nguyen HG, Chinnappan D, Urano T, Ravid K (2005). Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property. Mol Cell Biol 25, 4977-4992.
61. Nilsson J, Yekezare M, Minshull J, Pines J (2008). The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction. Nat Cell Biol 10, 1411-1420.
62. Oikawa T, Okuda M, Ma Z, Goorha R, Tsujimoto H, Inokuma H, Fukasawa K (2005). Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR1. Mol Cell Biol 25, 4046-4061.
63. Ozenne P, Eymin B, Brambilla E, Gazzeri S (2010). The ARF tumor suppressor: structure, functions and status in cancer. Int J Cancer 127, 2239-2247.
64. Parekh H, Simpkins H (1996). Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system. Biochem Pharmacol 51, 301-311.
65. Petersen J, Hagan IM (2003). S. pombe aurora kinase/survivin is required for chromosome condensation and the spindle checkpoint attachment response. Curr Biol 13, 590-597.
66. Pomerantz J, Schreiber-Agus N, Liégeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, et al. (1998). The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723.
67. Qi Y, Gregory MA, Li Z, Brousal JP, West K, Hann SR (2004). p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 431, 712-717.
68. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995). Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000.
69. Ricke RM, van Ree JH, van Deursen JM (2008). Whole chromosome instability and cancer: a complex relationship. Trends Genet 24, 457-466.
70. Rieder CL, Cole RW, Khodjakov A, Sluder G (1995). The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. J Cell Biol 130, 941-948.
71. Rieder CL, Maiato H (2004). Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 7, 637-651.
72. Rieder CL, Schultz A, Cole R, Sluder G (1994). Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle. J Cell Biol 127, 1301-1310.
73. Ryan SD, Britigan EM, Zasadil LM, Witte K, Audhya A, Roopra A, Weaver BA (2012). Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons. Proc Natl Acad Sci USA 109, E2205-E2214.
74. Santaguida S, Vernieri C, Villa F, Ciliberto A, Musacchio A (2011). Evidence that Aurora B is implicated in spindle checkpoint signalling independently of error correction. EMBO J 30, 1508-1519.
75. Schvartzman JM, Duijf PH, Sotillo R, Coker C, Benezra R (2011). Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 19, 701-714.
76. Schvartzman JM, Sotillo R, Benezra R (2010). Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 10, 102-115.
77. Silk AD, Zasadil LM, Holland AJ, Vitre B, Cleveland DW, Weaver BA (2013). Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors. Proc Natl Acad Sci USA 110, E4134-E4141.
78. Silkworth WT, Nardi IK, Scholl LM, Cimini D (2009). Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells. PLoS One 4, e6564.
79. Sironi L, Melixetian M, Faretta M, Prosperini E, Helin K, Musacchio A (2001). Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for the spindle checkpoint. EMBO J 20, 6371-6382.
80. Sorrentino R, Libertini S, Pallante PL, Troncone G, Palombini L, Bavetsias V, Spalletti-Cernia D, Laccetti P, Linardopoulos S, Chieffi P, et al. (2005). Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. J Clin Endocrinol Metab 90, 928-935.
81. Sotillo R, Hernando E, Diaz-Rodriguez E, Teruya-Feldstein J, Cordon-Cardo C, Lowe SW, Benezra R (2007). Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9-23.
82. Taylor SS, Hussein D, Wang Y, Elderkin S, Morrow CJ (2001). Kinetochore localisation and phosphorylation of the mitotic checkpoint components Bub1 and BubR1 are differentially regulated by spindle events in human cells. J Cell Sci 114, 4385-4395.
83. Thompson SL, Compton DA (2011). Chromosome missegregation in human cells arises through specific types of kinetochore-microtubule attachment errors. Proc Natl Acad Sci USA 108, 17974-17978.
84. Vader G, Cruijsen CW, van Harn T, Vromans MJ, Medema RH, Lens SM (2007). The chromosomal passenger complex controls spindle checkpoint function independent from its role in correcting microtubule kinetochore interactions. Mol Biol Cell 18, 4553-4564.
85. Vischioni B, Oudejans JJ, Vos W, Rodriguez JA, Giaccone G (2006). Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol Cancer Ther 5, 2905-2913.
86. Vleugel M, Hoogendoorn E, Snel B, Kops GJ (2012). Evolution and function of the mitotic checkpoint. Dev Cell 23, 239-250.
87. Weaver BA, Cleveland DW (2006). Does aneuploidy cause cancer? Curr Opin Cell Biol 18, 658-667.
88. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW (2007). Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11, 25-36.
89. Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ, Zambetti GP (2000a). p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev 14, 2358-2365.
90. Weber JD, Kuo ML, Bothner B, DiGiammarino EL, Kriwacki RW, Roussel MF, Sherr CJ (2000b). Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol Cell Biol 20, 2517-2528.
91. Yarbrough WG, Bessho M, Zanation A, Bisi JE, Xiong Y (2002). Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res 62, 1171-1177.
92. Zasadil LM, Britigan EM, Weaver BA (2013). 2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells. Semin Cell Dev Biol 24, 370-379.
93. Zhang Y, Xiong Y, Yarbrough WG (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734.